Physician profile
George Charuk
NPI 1679547079
$501.49
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $14.17 · 2021: $146 · 2022: $106.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $157.78 | 2019 | |
| Djo, LLC | $86.38 | 2022 | |
| Catalyst Orthoscience | $83.09 | 2021 | |
| Collegium Pharmaceutical, INC. | $47.05 | 2019 | |
| Bioventus LLC | $37.80 | 2021-2022 | |
| Ethicon US, LLC | $24.69 | 2021 | |
| Nevro Corp. | $20.22 | 2021 | |
| Pfizer INC. | $16.00 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.31 | 2019 | |
| Fidia Pharma USA INC. | $14.17 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Charuk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.